Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Novolog Mix 70/30 Generic Name & Formulations
Legal Class
Rx
General Description
Insulin aspart protamine suspension 70% (rDNA origin), insulin aspart 30% (rDNA origin) 100 Units/mL; SC inj; contains zinc, m-cresol.
How Supplied
Vials (10mL)—1; FlexPen (3mL)—1
Manufacturer
Generic Availability
NO
Novolog Mix 70/30 Indications
Indications
Diabetes.
Novolog Mix 70/30 Dosage and Administration
Adult
For SC inj only. Onset 10–20mins, peak 1.8–3.6hrs, duration up to 24hrs.
Children
Not established.
Novolog Mix 70/30 Contraindications
Contraindications
During episodes of hypoglycemia.
Novolog Mix 70/30 Boxed Warnings
Not Applicable
Novolog Mix 70/30 Warnings/Precautions
Warnings/Precautions
Instruct patients on proper administration of insulin, check insulin label before each injection, and management of hypoglycemia. Do not reuse or share pens between patients, even if the needle is changed (or needles and syringes when using vials). Do not inject into areas of lipodystrophy or localized cutaneous amyloidosis. Increased risk of hyperglycemia or hypoglycemia if changes in physical activity, meal patterns, renal or hepatic function, insulin regimen, administration site; and if acute illness occurs: monitor glucose more frequently and may need to adjust dose. Monitor potassium levels in patients at risk for hypokalemia (eg, concomitant K+-lowering or K+-sensitive drugs). Discontinue if hypersensitivity reactions occur. Hyperglycemia and ketoacidosis due to insulin pump device malfunction: see full labeling. Visual impairment. Renal or hepatic impairment. Pregnancy. Nursing mothers.
Novolog Mix 70/30 Pharmacokinetics
See Literature
Novolog Mix 70/30 Interactions
Interactions
Concomitant thiazolidinediones (TZDs) may cause fluid retention and heart failure; consider dose reduction or discontinue TZDs. Potentiated by oral antidiabetic agents, ACE inhibitors, ARBs, disopyramide, fibrates, fluoxetine, MAOIs, pentoxifylline, pramlintide, propoxyphene, salicylates, somatostatin analog, sulfonamide antibiotics. Antagonized by atypical antipsychotics, corticosteroids, isoniazid, niacin, danazol, diuretics, glucagon, thiazides, phenothiazines, sympathomimetics, somatropin, thyroid hormones, estrogens, progestogens, protease inhibitors. Variable effects with β-blockers, clonidine, lithium salts, alcohol, pentamidine. Concomitant β-blockers, clonidine, guanethidine, reserpine may blunt hypoglycemia. Do not mix with other insulins.
Novolog Mix 70/30 Adverse Reactions
Adverse Reactions
Hypoglycemia, hypokalemia, local inj site reactions, lipodystrophy, rash, pruritus, edema, sodium retention, weight gain; hypersensitivity and allergic reactions.
Novolog Mix 70/30 Clinical Trials
See Literature
Novolog Mix 70/30 Note
Not Applicable
Novolog Mix 70/30 Patient Counseling
See Literature
Images
